| abstract |
The present invention relates to the use of oxazolines and the cosmetic and pharmaceutical compositions comprising them, for inhibiting the migration of Langerhans cells (CL). The corresponding cosmetic treatment methods are also claimed, in particular within the framework of the treatment of skin pathologies, such as eczema, psoriasis and dermatoses and of the prevention of pathologies of allergic and / or inflammatory and / or irritative and / or irritative origins. or as part of the treatment of skin discomfort (sensitive, reactive or intolerant skin). |